Video Experimental Relacionado
Updated: May 3, 2026
06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 25, 2010
17.6K
Técnicas multimodal para el diagnóstico y pronóstico de la enfermedad de Alzheimer
Richard J Perrin1, Anne M Fagan, David M Holtzman
1Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8111, St Louis, Missouri 63110, USA.
Nature
|October 16, 2009
Resumen
La enfermedad de Alzheimer implica el mal plegamiento de proteínas cerebrales años antes de la demencia. Las nuevas técnicas de imágenes y biomarcadores pueden permitir la detección temprana y la intervención para esta enfermedad neurodegenerativa.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Neurología Neurología.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La enfermedad de Alzheimer (EA) es un problema de salud mundial que afecta a millones de personas.
- La enfermedad de Alzheimer se caracteriza por un mal plegamiento de las proteínas y el posterior daño cerebral, que precede a la aparición de la demencia.
- Los tratamientos actuales no pueden prevenir o retrasar la progresión de la enfermedad de Alzheimer.
Objetivo del estudio:
- Para resaltar los avances en la detección preclínica de la patología de la enfermedad de Alzheimer.
- Hacer hincapié en el potencial de las intervenciones terapéuticas tempranas basadas en mecanismos.
- Informar el diseño de futuros ensayos clínicos para la enfermedad de Alzheimer.
Principales métodos:
- Utilizando nuevas técnicas de neuroimagen.
- Empleando análisis avanzados de biomarcadores de fluidos.
- Investigando las etapas preclínicas de la enfermedad de Alzheimer.
Principales resultados:
- La patología de la enfermedad de Alzheimer es detectable en etapas preclínicas.
- Las nuevas herramientas de diagnóstico son prometedoras para la identificación temprana de AD.
- La detección temprana facilita las estrategias terapéuticas oportunas.
Conclusiones:
- Los avances en neuroimagen y biomarcadores permiten la detección preclínica de la enfermedad de Alzheimer.
- La identificación temprana abre caminos para tratamientos basados en mecanismos.
- Estos desarrollos son cruciales para el diseño de ensayos clínicos eficaces de la enfermedad de Alzheimer.
Videos de Conceptos Relacionados
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35